PRO362 polypeptides
US7282565B2 · kind B2 · utility
22Cited by
5References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 29, 2004 |
| Grant date | Oct 16, 2007 |
| Priority date | — |
| Expiry date | Jan 29, 2024 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to compositions and methods of treating and diagnosing disorders characterized the by the presence of antigens associated with inflammatory diseases and/or cancer, and nucleotide sequences, including expressed sequence tags (ESTs), oligonucleotide probes, polypeptides, vectors and host cells expressing such antigens PRO301, PRO362 or PRO245.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.